The FDA Law Blog

SEPTEMBER 12, 2023

More than 40 registrants — primarily hospitals and pharmacies — have paid significant civil penalties of up to $5,000,000 to settle allegations they failed to report controlled substance thefts or significant losses to the Drug Enforcement Administration (DEA). The risks to hospitals and pharmacies are multi-faceted and growing.

Controlled Substances 49

Controlled Substances Hospitals 49

The FDA Law Blog

SEPTEMBER 26, 2023

More than 40 registrants — primarily hospitals and pharmacies — have paid significant civil penalties of up to $5,000,000 to settle allegations they failed to report controlled substance thefts or significant losses to the Drug Enforcement Administration (DEA). The risks to hospitals and pharmacies are multi-faceted and growing.

Controlled Substances 45

Controlled Substances Hospitals 45

The FDA Law Blog

MAY 3, 2023

Accounting for controlled substances, maintaining complete and accurate records/reports and employing effective, compliant security do not alone guarantee a successful Drug Enforcement Administration (“DEA”) inspection. Registrants are far from powerless when DEA investigators inspect their controlled substance operations.

Controlled Substances 52

Controlled Substances 52

The FDA Law Blog

MAY 22, 2023

Accounting for controlled substances, maintaining complete and accurate records/reports and employing effective, compliant security do not alone guarantee a successful Drug Enforcement Administration (“DEA”) inspection. Registrants are far from powerless when DEA investigators inspect their controlled substance operations.

Controlled Substances 40

Controlled Substances 40

The FDA Law Blog

FEBRUARY 19, 2023

Houck was a diversion investigator with the Drug Enforcement Administration (“DEA”) in the field and at agency headquarters for 15 years before joining HPM in 2001. The session will occur Friday, March 24th.

Controlled Substances 59

Controlled Substances Immunization 59

The Checkup by Singlecare

MARCH 28, 2024

It works by increasing natural substances within the brain, which may help improve the ability to focus, stay attentive, and manage behavior. Food and Drug Administration (FDA) in 2001 , Adderall XR has become a popular medication for managing symptoms of ADHD. Following its approval by the U.S.

Dosage 93

Dosage Insurance Coverage Insurance Labelling 93

The FDA Law Blog

FEBRUARY 11, 2024

Not surprisingly, then-presidential candidate Asa Hutchinson, DEA Administrator from 2001 to 2003, did not sign the letter. The letter is signed by six former DEA administrators and five former Directors of National Drug Policy. The earliest tenured is John Bartels, who served as Administrator from 1973 to 1975.

Controlled Substances 59

Controlled Substances Chemotherapy Compounding FDA 59